David Hollander's Net Worth
$60.8 Thousand
Who is David Hollander?
David Hollander does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KIORA PHARMACEUTICALS INC, and AERIE PHARMACEUTICALS INC.
SEC CIK
David Hollander's CIK is 0001793796
Past Insider Trading and Trends
2019 was David Hollander's most active year for acquiring shares with 2 total transactions. David Hollander's most active month to acquire stocks was the month of January. 2020 was David Hollander's most active year for disposing of shares, totalling 1 transactions. David Hollander's most active month to dispose stocks was the month of October. 2019 saw David Hollander paying a total of $0.00 for 135,000 shares, this is the most they've acquired in one year. In 2020 David Hollander cashed out on 2,162 shares for a total of $28,214.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KIORA PHARMACEUTICALS INC (KPRX) Snapshot price: $0.8088
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AERIE PHARMACEUTICALS INC No price found
Chief R&D Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.93% | -927.00 |
$7.05 | -$6,535.35 | 30.75K |
Feb 4
| |||
Form 4
| -6.39% | -2.16K |
$12.06 | -$26,073.72 | 31.68K |
Nov 11
| |||
Form 4
| +48.17% | 11K |
—
|
—
| 33.84K |
Feb 4
| |||
Form 4
| -8.65% | -2.16K |
$13.05 | -$28,214.10 | 22.84K |
Nov 11
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revance Therapeutics, Inc. (RVNC) No price found
CMO & Global Therapeutics Lead
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||